{"id":8060,"date":"2022-12-29T12:43:23","date_gmt":"2022-12-29T10:43:23","guid":{"rendered":"https:\/\/www.norameda.com\/kara-ietekme-uz-cae-tirgu-un-baltijas-unikalitate\/"},"modified":"2022-12-29T12:43:23","modified_gmt":"2022-12-29T10:43:23","slug":"kara-ietekme-uz-cae-tirgu-un-baltijas-unikalitate","status":"publish","type":"post","link":"https:\/\/www.norameda.com\/lv\/kara-ietekme-uz-cae-tirgu-un-baltijas-unikalitate\/","title":{"rendered":"Kara ietekme uz CAE tirgu un Baltijas unikalit\u0101te"},"content":{"rendered":"

Pirms da\u017e\u0101m ned\u0113\u013c\u0101m m\u0113s sniedz\u0101m pasaules farm\u0101cijas tirgus apskatu. \u0160oreiz m\u0113s v\u0113lamies j\u016bs inform\u0113t par tendenc\u0113m Eiropas Kopien\u0101 un \u012bpa\u0161i Baltijas valst\u012bs.<\/p>\n

Kara ietekme <\/strong><\/h3>\n

Pirmk\u0101rt un galvenok\u0101rt, re\u0123ionu b\u016btiski ietekm\u0113 kar\u0161 Ukrain\u0101. Pirms kara mums bija piecas galven\u0101s politisk\u0101s t\u0113mas, kas ietekm\u0113ja Eiropas situ\u0101ciju 2022.\u00a0gad\u0101: digit\u0101l\u0101 transform\u0101cija vesel\u012bbas apr\u016bp\u0113, inov\u0101ciju pieejam\u012bba pacientiem, produktu tr\u016bkuma probl\u0113mas risin\u0101\u0161ana, ESG<\/em> (vides, soci\u0101l\u0101s un korporat\u012bv\u0101s p\u0101rvald\u012bbas) pieaugo\u0161\u0101 noz\u012bme un pieg\u0101\u017eu dro\u0161\u012bbas uzlabo\u0161ana.<\/p>\n

Kad s\u0101k\u0101s kar\u0161, Ukrainas kr\u012bze saasin\u0101ja nevienl\u012bdz\u012bbu. Dr\u012bzum\u0101 jau eso\u0161\u0101s probl\u0113mas b\u016bs v\u0113l paman\u0101m\u0101kas un as\u0101kas. M\u0113s jau varam redz\u0113t strauju piepras\u012bjuma pieaugumu Austrumeirop\u0101, ra\u017eot\u0101ju izmaksu un atmaksas nepiecie\u0161am\u012bbas palielin\u0101\u0161anos, kas izraisa izmaksu pieaugumu apk\u0101rt eso\u0161\u0101m valst\u012bm un trauc\u0113 kl\u012bniskajiem p\u0113t\u012bjumiem.<\/p>\n

Infl\u0101cija un ener\u0123ijas izmaksas strauji pieaug galveno tirgu liel\u0101kaj\u0101 da\u013c\u0101, un tas b\u016bs j\u016btams vis\u0101 nozar\u0113. Turkl\u0101t m\u0113s v\u0113rojam ar\u012b, ka no tirgus aiziet Rietumu uz\u0146\u0113mumi: pirmie daudznacion\u0101lie uz\u0146\u0113mumi (Bristol Myers Squibb<\/em> un Reckitt<\/em>) ir atst\u0101ju\u0161i tirgu, nododot savu da\u013cu Krievij\u0101 tre\u0161aj\u0101m person\u0101m. Visticam\u0101k, sekos ar\u012b citi.<\/p>\n

Izmaksu pieaugums <\/strong><\/h3>\n

Turkl\u0101t m\u0113s saskaramies ar izmai\u0146\u0101m medikamentoz\u0101 \u0101rst\u0113\u0161an\u0101 un jauno produktu izlai\u0161anas proces\u0101. Tas paliek d\u0101rg\u0101ks un individu\u0101l\u0101ks \u2013 specializ\u0113t\u0101 produkcija p\u0101rsp\u0113j tradicion\u0101lo un daudz\u0101s Eiropas valst\u012bs tagad veido jau vair\u0101k nek\u0101 pusi no tirgus v\u0113rt\u012bbas.<\/p>\n

Run\u0101jot par galvenajiem virz\u012bt\u0101jsp\u0113kiem farm\u0101cijas tirgus izaugsmei l\u012bdz 2030. gadam, onkolo\u0123ija joproj\u0101m paliek domin\u0113jo\u0161\u0101 terapijas joma. Ar\u012b \u0161\u016bnu, g\u0113nu un RNS virzieni ir inov\u0101ciju priek\u0161gal\u0101, rodot pielietojumu vair\u0101k\u0101s terapijas jom\u0101s. Saglab\u0101jas p\u0113d\u0113jo laiku tendence, digit\u0101lajai vesel\u012bbai ie\u0146emot arvien liel\u0101ku lomu. Turkl\u0101t, ir iesp\u0113jas v\u0101ji apmierin\u0101t\u0101s jom\u0101s, piem\u0113ram, Alcheimera, Parkinsona slim\u012bbu un gar\u012bg\u0101s vesel\u012bbas trauc\u0113jumu jom\u0101.<\/p>\n

Atvese\u013co\u0161an\u0101s un notur\u012bba (RR) b\u016btiski ietekm\u0113s vesel\u012bbas apr\u016bpes bud\u017eetu un att\u012bst\u012bbu. RR paketes kop\u0113jais bud\u017eets pa\u0161laik ir 672,6 miljardi eiro, no kuriem 312,6 ir dot\u0101ciju veid\u0101, kas ir j\u0101\u012bsteno l\u012bdz 2026.\u00a0gadam.<\/p>\n

Baltijas tirgus pulss<\/strong><\/h3>\n

Baltijas tirgi p\u0113d\u0113jo piecu gadu laik\u0101 ir augu\u0161i (+8,3%). Augo\u0161\u0101s kategorijas ir recep\u0161u z\u0101les +16% un bezrecep\u0161u z\u0101les +16%.<\/p>\n

Tom\u0113r starp Lietuvu, Latviju, Igauniju un Rietumeiropas valst\u012bm joproj\u0101m saglab\u0101jas iev\u0113rojama at\u0161\u0137ir\u012bba z\u0101\u013cu pat\u0113ri\u0146\u0101. Kopum\u0101 politisk\u0101 vide un demogr\u0101fisk\u0101s tendences (jo \u012bpa\u0161i novecojo\u0161a un bag\u0101t\u0101ka sabiedr\u012bba) ir labv\u0113l\u012bgas vis\u0101s valst\u012bs. Tom\u0113r Lietuvas un Latvijas iedz\u012bvot\u0101ju skaits ir samazin\u0101jies par 4% negat\u012bvas kop\u0113j\u0101s migr\u0101cijas un zem\u0101 dzimst\u012bbas l\u012bme\u0146a d\u0113\u013c.<\/p>\n

Kop\u0113j\u0101 mazumtirdzniec\u012bbas tirgus v\u0113rt\u012bba Baltij\u0101 ir ~1,88 miljardi EUR. Ta\u010du ar\u012b infl\u0101cijas l\u012bmenis ir augst\u0101kais vismaz desmit gados un turpina augt.<\/p>\n

Kas ir unik\u0101ls Baltijas valst\u012bs? <\/strong><\/h3>\n

Baltijas tirgus izce\u013cas ar lielu tirdzniec\u012bbas \u0137\u0113\u017eu \u012bpatsvaru: gandr\u012bz vis\u0101m lielaj\u0101m \u0137\u0113d\u0113m ir savi z\u012bmoli un t\u0101s izstr\u0101d\u0101 jaunus produktus. Lietuv\u0101 liela da\u013ca priv\u0101to pre\u010du z\u012bmju nav pieejama pie izplat\u012bt\u0101jiem. Liel\u0101kajai da\u013cai \u0137\u0113\u017eu ir tie\u0161saistes aptiekas.<\/p>\n

V\u0113l viena at\u0161\u0137ir\u012bba ir t\u0101, ka Baltij\u0101 ir augsti att\u012bst\u012bts \u0137\u0113\u017eu tirgus, un pat\u0113r\u0113t\u0101ji, visticam\u0101k, izv\u0113l\u0113sies apmekl\u0113t aptieku, nevis \u0101rstu. Ir paredzams ar\u012b, ka aptuveni 40% no visas mijiedarb\u012bbas ar farm\u0101cijas p\u0101rst\u0101vjiem notiks, izmantojot digit\u0101los kan\u0101lus.<\/p>\n

Prognoze liecina par atvese\u013co\u0161an\u0101s tendenci visam tirgum par +11,3% 2022.\u00a0gad\u0101 un +4,5% 2023.\u00a0gad\u0101. Tirgus prognozes Lietuvai uzr\u0101da izaugsmi no 4,8% l\u012bdz 6,5%, Igaunijai no 5,5% l\u012bdz 9,1% un Latvijai no 1,5% l\u012bdz 3,1% 2023.\u00a0gad\u0101.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pirms da\u017e\u0101m ned\u0113\u013c\u0101m m\u0113s sniedz\u0101m pasaules farm\u0101cijas tirgus apskatu. \u0160oreiz m\u0113s v\u0113lamies j\u016bs inform\u0113t par tendenc\u0113m Eiropas Kopien\u0101 un \u012bpa\u0161i Baltijas valst\u012bs. Kara ietekme Pirmk\u0101rt un galvenok\u0101rt, re\u0123ionu b\u016btiski ietekm\u0113 kar\u0161 Ukrain\u0101. Pirms kara mums bija piecas galven\u0101s politisk\u0101s t\u0113mas, kas ietekm\u0113ja Eiropas situ\u0101ciju 2022.\u00a0gad\u0101: digit\u0101l\u0101 transform\u0101cija vesel\u012bbas apr\u016bp\u0113, inov\u0101ciju pieejam\u012bba pacientiem, produktu tr\u016bkuma probl\u0113mas […]<\/p>\n","protected":false},"author":220,"featured_media":3061,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[141],"tags":[],"_links":{"self":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8060"}],"collection":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/users\/220"}],"replies":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/comments?post=8060"}],"version-history":[{"count":0,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media\/3061"}],"wp:attachment":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media?parent=8060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/categories?post=8060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/tags?post=8060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}